News

Deal features $45 million for commercialization of several Big Pharma products

Trading partner Interconnections via the EPCIS standard is a basic requirement

Company builds on its sample accountability platform

Site construction is part of a 10-year agreement with the Australian government

Crēdo ProEnvision Software 2.0, company says, expected to improve the customer experience for cold chain clients

Accreditation further extends CDMO's viral vector manufacturing capacity

Acquisition expected to be finalized in April

Survey conducted by HDA reveals thought process of manufacturers, distributors, and 3PLs

Moderna, Pfizer, and BioNTech seeking FDA approval for fourth dose of their respective shots

Platform combines data, software, and insights “into single ecosystem.”

Latest report suggests a slower rate of growth and constrained capacity

Shipment from Basel, Switzerland, to JFK airport, New York, consisted of three Releye RAP units and two RAP e2 units.

Acquisition of data-driven prescription drug benefit and affordability company will ”help patients overcome financial barriers to starting and staying on therapy.”

New center comes in response to increasing demand for firm’s medicines

Acquires MarketShare Movers, as company aims to provide patients with affordability services

CDMO’s Chenôve facility receives investment from French government

Deal expected to help expand its API production services

Agreement establishes company’s first mRNA manufacturing facility in Africa

Healthcare market research and insights company will become part of Ashfield Advisory.

The deal features a long-term supply and production agreement between the parties

Expansion features 11 new cGMP labs at Durham, NC location

If given green light by European Commission, vaccine dose will be less than that of adolescents

GTS improvements include additional data integrity protection, greater Level 1 and 2 equipment compatibility

The latest people news happenings over the past month

New consortium provides integrated solution with specialist services, from biologics discovery to clinical and commercial manufacturing.

The parties are partnering up to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies

Advance purchase agreement is for up to 200 million doses of Nuvaxovid

Discussions will revolve around fortifying the pharma supply chain